Alnylam Pharmaceuticals, Inc.
ALNY· Nasdaq
ALNYAlnylam Pharmaceuticals, Inc.
Filed May 8, 2015 · 10-Q · 38 days after period end · 0001193125-15-178432
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Net Income | -$50.78M | -$250.94M | -$9.01M | -$11.37M |
| EPS Diluted | -$0.62 | -$3.70 | -$0.15 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alnylam Pharmaceuticals, Inc. · CIK 1178670 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 8, 2015 · 38 d after period end
